The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancer
about
The quest to overcome resistance to EGFR-targeted therapies in cancer.Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapiesFollowing the crumbs: from tissue samples, to pharmacogenomics, to NSCLC therapyAutophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M.Erlotinib resistance in lung cancer: current progress and future perspectives.New targetable oncogenes in non-small-cell lung cancer.Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorTargeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancerCovalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance.Role of human epidermal growth factor receptor 2 in gastric cancer: biological and pharmacological aspects.Rationale for targeting the ErbB family of receptors in patients with advanced squamous cell carcinoma of the lung.Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer.Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapyHeat shock protein 70 inhibitors. 1. 2,5'-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides as irreversible binders to an allosteric site on heat shock protein 70Covalent Inhibition of HIV-1 Integrase by N-Succinimidyl Peptides.Is there a third line option after chemotherapy and TKI failure in advanced non-small cell lung cancer?A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck.[Novel morphological and molecular aspects of lung cancer].LC-MS/MS assay for the quantitation of the tyrosine kinase inhibitor neratinib in human plasma.A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models.[Adverse events of afatinib as first-line treatment for five cases of advanced lung adenocarcinoma and review of literature].
P2860
Q33725976-DDE76A1F-2E7B-42D7-AED0-88BC7CF6AD09Q34158454-768D0E01-601B-40FE-85AB-BF9CAB210B09Q35200424-1F720F48-DC52-4DC8-9BBC-F6210C09D5F2Q35500311-AEE9FA32-13D1-4F5E-8DA4-122F8215A741Q36605522-71AF5A68-45EC-46E5-BE37-BC48379E4762Q36660677-7846A8B5-0927-4626-AD61-9ECD89BDDC7BQ37011144-98A6FD46-5D1E-4957-8267-A85E02D144BCQ37246286-9D6F8BA4-1CAB-4819-8045-2936CE48BD93Q37475183-660AFE6F-CC43-4D7F-B774-73D6B4C3CE1EQ37724647-D779A514-2438-4A6D-954C-BA3922F3EB53Q38514601-D124D469-1DAD-43D8-99F0-3803FE604F31Q38525856-D047A8C9-1F88-4EEA-A706-1FE204D41A9AQ38598893-D842D217-914A-4934-915E-7351E401320DQ38705756-CB92C0C7-284E-4378-B3B8-206EE3AF2BDAQ40688076-489778AE-F2BC-4066-BCCE-139FE756DEEFQ41813499-04669EA6-0A66-40D7-8BB2-C84484633BB2Q44336355-7575FDBD-80D0-4BE5-BBD9-013CCD4179EDQ45264604-1C2A289F-7A0C-4D52-A14B-40EEF83E638FQ49530239-C65DEDF5-BC91-4C85-A221-5D4904E82D03Q51110603-1BB4E1F9-484E-47FA-AE40-9ED9C3241EF6Q55464231-0F180E29-0AB2-4D12-B52B-E690B1216597
P2860
The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancer
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The role of irreversible HER f ...... ith non-small cell lung cancer
@ast
The role of irreversible HER f ...... ith non-small cell lung cancer
@en
The role of irreversible HER f ...... ith non-small cell lung cancer
@nl
type
label
The role of irreversible HER f ...... ith non-small cell lung cancer
@ast
The role of irreversible HER f ...... ith non-small cell lung cancer
@en
The role of irreversible HER f ...... ith non-small cell lung cancer
@nl
prefLabel
The role of irreversible HER f ...... ith non-small cell lung cancer
@ast
The role of irreversible HER f ...... ith non-small cell lung cancer
@en
The role of irreversible HER f ...... ith non-small cell lung cancer
@nl
P2860
P1433
P1476
The role of irreversible HER f ...... ith non-small cell lung cancer
@en
P2093
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0087
P407
P577
2011-01-01T00:00:00Z